Intracerebral Hemorrhage Trial - Nationwide record Trial, NRW

Intracerebral Hemorrhage Trial - Nationwide record Trial, NRW - ICB-Register NRW

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011098

Enrollment

500

Registered

2017-09-05

Start date

2017-06-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I61.9

Interventions

Group 1: Patients with a new spontaneous intracerebral hemorrhage. At the time of the event: Bleeding type, neurostatus, patient characteristics, risk factors. Over the course of the Hospital stay: co

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients must be = 18 years old, - Written statement of consent and consent to participate at the Trial. - Patients suffering from a new spontaneous intracerebral hemorrhage (ICH).

Exclusion criteria

Exclusion criteria: Injury of clinical inclusion criteria (eg traumatic genesis of hemorrhage , tumorous cause of hemorrhage)

Design outcomes

Primary

Measure	Time frame
Neurological and clinical condition of the patients after 6 and 12 months, overall mortality and necessity of surgical revisions. The neurological grade of recovery of the patients will be analysed based on established and standardized neurological graduation scales (GOS, mRS, SF 12) 6 and 12 months after hemorrhage. Any individual cause of death within 6 and 12 month will be noticed. Analysis of risk profiles for surgically treated patients and Impact on outcome	—

Measure

Time frame

Neurological and clinical condition of the patients after 6 and 12 months, overall mortality and necessity of surgical revisions. The neurological grade of recovery of the patients will be analysed based on established and standardized neurological graduation scales (GOS, mRS, SF 12) 6 and 12 months after hemorrhage. Any individual cause of death within 6 and 12 month will be noticed. Analysis of risk profiles for surgically treated patients and Impact on outcome

—

Secondary

Measure	Time frame
The aim of this observational study on patients with spontaneous ICH is to evaluate the collected information on the quality assurance of the therapeutic modalities and influence of several factors on outcome, e.g. Context of hemorrhage type (localization, size) and clinical outcome, - influence of the selected Treatment strategy(conservative, surgical), - effects of possible additional intensive-care modalities (e.g., blood pressure levels, transfusion of blood products and coagulation substitution) - influence of the time factor up to hospitalization, - Influence of additional procedures (external ventricular drainage, lumbar CSF drainage, VP shunt, decompressive hemikraniectomy), - and their comparison, - the balancing of the perioperative / postoperative risk of complications and - clinical outcome for the assessment of the therapy	—

Measure

Time frame

The aim of this observational study on patients with spontaneous ICH is to evaluate the collected information on the quality assurance of the therapeutic modalities and influence of several factors on outcome, e.g. Context of hemorrhage type (localization, size) and clinical outcome, - influence of the selected Treatment strategy(conservative, surgical), - effects of possible additional intensive-care modalities (e.g., blood pressure levels, transfusion of blood products and coagulation substitution) - influence of the time factor up to hospitalization, - Influence of additional procedures (external ventricular drainage, lumbar CSF drainage, VP shunt, decompressive hemikraniectomy), - and their comparison, - the balancing of the perioperative / postoperative risk of complications and - clinical outcome for the assessment of the therapy

—

Countries

Germany

Contacts

Public ContactAzize Boström

Klinik für Neurochirurgie, Universitätsklinikum Bonn

Azize.Bostroem@ukb.uni-bonn.de+49 (0)228 287 16537

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026